Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three drugs—lidocaine, epinephrine, and fentanyl—used primarily in regional anesthesia (such as epidural or spinal anesthesia) for surgical procedures including cesarean section. - **Lidocaine** is an amide-type local anesthetic that works by blocking sodium channels (specifically the sodium channel protein type 1 subunit alpha), thereby inhibiting nerve impulse conduction and producing loss of sensation in the targeted area[4]. - **Epinephrine** acts as a vasoconstrictor by stimulating adrenergic receptors (alpha-adrenergic receptor agonist), which reduces systemic absorption of lidocaine, prolongs its effect, and decreases bleeding at the site[1][3][6]. - **Fentanyl** is a potent synthetic opioid analgesic that acts primarily on mu-opioid receptors to provide additional pain relief during procedures[7][8]. The addition of fentanyl to lidocaine/epinephrine solutions has been shown to increase the duration and quality of postoperative analgesia without significantly increasing adverse effects. This combination is commonly used in obstetric anesthesia for cesarean sections due to its efficacy in providing rapid onset sensory block with prolonged pain control[1][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + epinephrine + fentanyl.